Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Harefuah|July 28, 2009
[Chronic use of sleep medications--how serious is it in Israel?]Yaron Dagan, Marina Dushenat, Barbara SilvermanHematological Oncology|May 31, 2016
Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-upTamar Tadmor, Irena Liphshitz, Barbara Silverman, et al.Leukemia & Lymphoma|July 3, 2020
Rituximab is not associated with increased risk of second primary malignancies in Israeli patients with diffuse large B cell lymphoma treated with RCHOP regimenYuval Neeman, Chava Perry, Barbara Silverman, et al.Leukemia & Lymphoma|September 7, 2018
The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort studyChezi Ganzel, Barbara Silverman, Daniel Chemtob, et al.Health Policy (Amsterdam, Netherlands)|June 18, 2013
Methodological challenges in international performance measurement using patient-level administrative dataRaul Kiivet, Reijo Sund, Miika Linna, et al.Cancer Epidemiology|December 22, 2020
Sarcoma incidence and subtype distribution in Israel - A population-based studyOded Icht, Ron Lewin, Lilach Yosef, et al.Cancer Causes & Control : CCC|July 24, 2022
Secondary cancer after meningioma diagnosis: an Israeli national studyMaya Ben Lassan, Yael Laitman, Lital Keinan-Boker, et al.Internal Medicine Journal|September 26, 2025
A large long-term database of Gaucher disease patients demonstrates increased risk of lymphoma and myeloma, but not of solid tumoursMajdolen Istaiti, Tama Dinur, Ora Paltiel, et al.Cancer Epidemiology|November 7, 2018
Risk of second primary neoplasm and mortality in childhood cancer survivors based on a national registry databaseSamah Hayek, Rita Dichtiar, Tamy Shohat, et al.Cancer Causes & Control : CCC|April 23, 2017
Primary prevention and screening practices among long-term breast cancer survivorsLori Mandelzweig, Angela Chetrit, Tova Amitai, et al.Pageof 4